AZD7325 Japan Multiple Ascending Dose (MAD) Study
NCT00945425 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 48
Last updated 2011-02-16
Summary
The purpose of this study is to evaluate the safety and tolerability after repeated ascending doses of AZD7325 in Japanese healthy male subjects.
Conditions
- Healthy
Interventions
- DRUG
-
AZD7325
oral capsule, once or twice daily, 7 days
- DRUG
-
oral capsule, once or twice daily, 7 days
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Yuji Kumagai, MD, PhD · Kitasato University East Hospital, Kanagawa, Japan
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- QUADRUPLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 20 Years
- Max Age
- 45 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-07-31
- Completion
- 2009-11-30
More Related Trials
-
Study to Investigate Safety, Tolerability and PK Following Single and Multiple Ascending Doses of AZD7295 in Japanese
NCT00818129 ·Status: COMPLETED ·Phase: PHASE1
-
Investigate the Safety Tolerability and Pharmacokinetics of Multiple Doses of AZD1236
NCT00767052 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Safety, Tolerability and Pharmacokinetics After Multiple Doses of AZD2066 in Japanese Subjects
NCT00766012 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate Safety and Tolerability Single Ascending Doses of AZD4017.
NCT00799747 ·Status: COMPLETED ·Phase: PHASE1
-
AZD8529 Single Ascending Dose Study in Healthy Japanese Subjects
NCT00886756 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess Safety, Tolerability and Pharmacokinetics After Single Dose of AZD2516 to Japanese Healthy Subjects
NCT00972049 ·Status: COMPLETED ·Phase: PHASE1
-
AZD7268 Single Ascending Dose Study in Healthy Japanese Subjects
NCT00912353 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD5462 Following Single and Multiple Ascending Dose Administration to Healthy Volunteers
NCT04994106 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of Inhaled Doses of AZD4818 in Healthy Japanese Male Volunteers
NCT00687232 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Pharmacokinetics and Pharmacodynamics After Single and Multiple Dosing of AZD5423 in Japanese Healthy Male Subjects
NCT01338350 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Multiple Ascending Dose Study for AZD 7268 in Healthy Volunteers
NCT00861718 ·Status: COMPLETED ·Phase: PHASE1
-
AZD7325 Multiple Ascending Dose Study
NCT00681915 ·Status: COMPLETED ·Phase: PHASE1
-
AZD2423 Single Ascending Dose Study in Healthy Japanese Subjects
NCT00970775 ·Status: COMPLETED ·Phase: PHASE1
-
Single and Multiple Ascending Doses of AZD1981 in Japan
NCT00698282 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD2423 Multiple Doses in Healthy Japanese Volunteers
NCT01233830 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability and Pharmacokinetics of Modified-Release Formulations of AZD1446 After Oral Single and Repeated Doses
NCT01199315 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess Safety, Tolerability and Pharmacokinetics After Single and Multiple Doses of AZD1446 to Japanese Subject
NCT01021189 ·Status: COMPLETED ·Phase: PHASE1
-
Assess the Safety, Tolerability and Pharmacokinetics of AZD5213 After Single and Multiple Ascending Oral Doses in Healthy Young and Elderly Japanese Subjects
NCT01335451 ·Status: COMPLETED ·Phase: PHASE1
-
Multiple-ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 in Healthy Male Subjects
NCT03435276 ·Status: COMPLETED ·Phase: PHASE1
-
A Single and Multiple Ascending Dose Study With AZD9164 Given for 13 Days in Healthy Male and Female Japanese Subjects
NCT01096563 ·Status: TERMINATED ·Phase: PHASE1
-
AZD5985 Single Ascending Dose Study
NCT00967356 ·Status: TERMINATED ·Phase: PHASE1
-
Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single Doses ofAZD2551
NCT00860353 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of a Single Ascending Dose of AZD0292 in Healthy Japanese Participants
NCT07222254 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Study to Investigate Safety and Tolerability Single Ascending Doses of AZD4017
NCT00791752 ·Status: COMPLETED ·Phase: PHASE1
-
AZD6423 SAD/MAD Study in Healthy Volunteers
NCT01926366 ·Status: COMPLETED ·Phase: PHASE1